These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8831016)

  • 1. Corticosteroids in rheumatoid arthritis.
    Haslock I
    Br J Hosp Med; 1996 Jun 19-Jul 9; 56(1):50. PubMed ID: 8831016
    [No Abstract]   [Full Text] [Related]  

  • 2. The new era in the treatment of rheumatoid arthritis.
    Putterman C
    Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):2-4. PubMed ID: 17694188
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 4. Modern drug treatment options for rheumatoid arthritis.
    Binning M
    Aust Nurs J; 2001 Apr; 8(9):suppl 1-3. PubMed ID: 11894377
    [No Abstract]   [Full Text] [Related]  

  • 5. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
    Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is attenuated COBRA treatment strategy (COBRA-light) non-inferior or not non-inferior than original COBRA strategy?
    Akar S; Tinazli M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 87):S-18. PubMed ID: 25327510
    [No Abstract]   [Full Text] [Related]  

  • 7. N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis?
    Pincus T; Huizinga TW; Yazici Y
    J Rheumatol; 2007 Feb; 34(2):250-2. PubMed ID: 17304647
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination therapy in early rheumatoid arthritis: the COBRA study].
    Boers M; Verhoeven AC; van der Linden S
    Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remodeling the pyramid--a concept whose time has not yet come.
    Hess EV; Luggen ME
    J Rheumatol; 1989 Sep; 16(9):1175-6. PubMed ID: 2572698
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis.
    Kirwan JR; Hällgren R; Mielants H; Wollheim F; Bjorck E; Persson T; Book C; Bowman S; Byron M; Cox N; Field M; Kanerud L; Leirisalo-Repo M; Malaise M; Mohammad A; Palmer R; Petersson IF; Ringertz B; Sheldon P; Simonsson M; Snowden N; Van den Bosch F
    Ann Rheum Dis; 2004 Jun; 63(6):688-95. PubMed ID: 15140776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations from an expert group: drug therapy of rheumatoid arthritis].
    Lakartidningen; 1992 May; 89(21):1923-6. PubMed ID: 1350802
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of rheumatoid arthritis].
    Babić-Naglić D
    Reumatizam; 2003; 50(2):22-7. PubMed ID: 15098369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis: new developments in the use of existing therapies.
    O'Dell JR; Scott DL
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():24-6. PubMed ID: 10646486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reconsideration of glucocorticoid therapy for rheumatoid arthritis].
    Ichikawa Y
    Ryumachi; 2002 Dec; 42(6):859-62. PubMed ID: 12632604
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modern medicinal agents used in rheumatoid arthritis].
    Akimov PP
    Med Sestra; 1990 Dec; 49(12):42-5. PubMed ID: 1982550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Arthritis of the atlanto-axial joint with inflammatory neck pain as a primary manifestation of seronegative rheumatoid arthritis].
    Haeusler U; Dybowski F; Wittkaemper TA; Kisters K; Godolias G; Braun J
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1729-32. PubMed ID: 20812156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [When to begin rheumatism treatment? Initial combination therapy helps fastest].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):5-6. PubMed ID: 15887691
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.